549 related articles for article (PubMed ID: 29850522)
1. Identification of Key Genes and miRNAs in Osteosarcoma Patients with Chemoresistance by Bioinformatics Analysis.
Xie B; Li Y; Zhao R; Xu Y; Wu Y; Wang J; Xia D; Han W; Chen D
Biomed Res Int; 2018; 2018():4761064. PubMed ID: 29850522
[TBL] [Abstract][Full Text] [Related]
2. Identification of Key miRNAs in the Treatment of Dabrafenib-Resistant Melanoma.
Gao G; Yao Z; Shen J; Liu Y
Biomed Res Int; 2021; 2021():5524486. PubMed ID: 33880366
[TBL] [Abstract][Full Text] [Related]
3. Screening candidate microRNA-mRNA network for predicting the response to chemoresistance in osteosarcoma by bioinformatics analysis.
Dai P; He Y; Luo G; Deng J; Jiang N; Fang T; Li Y; Cheng Y
J Cell Biochem; 2019 Oct; 120(10):16798-16810. PubMed ID: 31090103
[TBL] [Abstract][Full Text] [Related]
4. Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis.
Han B; Feng D; Yu X; Zhang Y; Liu Y; Zhou L
Med Sci Monit; 2018 Aug; 24():6059-6069. PubMed ID: 30168505
[TBL] [Abstract][Full Text] [Related]
5. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
[TBL] [Abstract][Full Text] [Related]
6. Identification of key biomarkers and functional pathways in osteosarcomas with lung metastasis: Evidence from bioinformatics analysis.
Liu D; Zhou R; Zhou A
Medicine (Baltimore); 2021 Feb; 100(6):e24471. PubMed ID: 33578541
[TBL] [Abstract][Full Text] [Related]
7. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
8. Identification of crucial miRNAs and genes in esophageal squamous cell carcinoma by miRNA-mRNA integrated analysis.
Zhong X; Huang G; Ma Q; Liao H; Liu C; Pu W; Xu L; Cai Y; Guo X
Medicine (Baltimore); 2019 Jul; 98(27):e16269. PubMed ID: 31277149
[TBL] [Abstract][Full Text] [Related]
9. Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays.
Shen H; Wang W; Ni B; Zou Q; Lu H; Wang Z
Int J Mol Med; 2018 Jul; 42(1):21-30. PubMed ID: 29620143
[TBL] [Abstract][Full Text] [Related]
10. In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer.
Baruah MM; Sharma N
Med Oncol; 2019 Apr; 36(5):43. PubMed ID: 30937635
[TBL] [Abstract][Full Text] [Related]
11. Investigation of crucial genes and microRNAs in conventional osteosarcoma using gene expression profiling analysis.
Peng C; Yang Q; Wei B; Yuan B; Liu Y; Li Y; Gu D; Yin G; Wang B; Xu D; Zhang X; Kong D
Mol Med Rep; 2017 Nov; 16(5):7617-7624. PubMed ID: 28944822
[TBL] [Abstract][Full Text] [Related]
12. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer.
Xue B; Li S; Jin X; Liu L
BMC Cancer; 2021 Apr; 21(1):452. PubMed ID: 33892654
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics Analysis of mRNAs and miRNAs for Identifying Potential Biomarkers in Lung Adenosquamous Carcinoma.
Nie J; Gong L; Li Z; Ou D; Zhang L; Liu Y; Zhang J; Liu D
Comput Math Methods Med; 2022; 2022():5851269. PubMed ID: 35281953
[TBL] [Abstract][Full Text] [Related]
15. Identification of Differentially Expressed Genes and miRNAs Associated with Esophageal Squamous Cell Carcinoma by Integrated Analysis of Microarray Data.
Zhang L; Chen J; Cheng T; Yang H; Pan C; Li H
Biomed Res Int; 2020; 2020():1980921. PubMed ID: 32714975
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
Qin X; Song Y
Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
[TBL] [Abstract][Full Text] [Related]
17. Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.
Piao J; Sun J; Yang Y; Jin T; Chen L; Lin Z
Gene; 2018 Mar; 647():306-311. PubMed ID: 29305979
[TBL] [Abstract][Full Text] [Related]
18. Screening and Interaction Analysis of Key Genes in miR-542-3p Over- Expressed Osteosarcoma Cells by Bioinformatics.
Li Z; Zhang P; Feng F; Zhang Q
Comb Chem High Throughput Screen; 2020; 23(5):411-418. PubMed ID: 32233998
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics Analysis Identifies MicroRNAs and Target Genes Associated with Prognosis in Patients with Melanoma.
Li Q; Zhang LY; Wu S; Huang C; Liu J; Wang P; Cao Y
Med Sci Monit; 2019 Oct; 25():7784-7794. PubMed ID: 31621692
[TBL] [Abstract][Full Text] [Related]
20. Study on potential differentially expressed genes in stroke by bioinformatics analysis.
Yang X; Wang P; Yan S; Wang G
Neurol Sci; 2022 Feb; 43(2):1155-1166. PubMed ID: 34313877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
